A feasibility study of the metronomic chemotherapy using oral tegafur-uracil and cyclophosphamide for recurrent gynecological cancers
Not Applicable
Recruiting
- Conditions
- advance and recurrent gynecological cancer
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) acute systemic inflammatory disease 2) uncontrolled cardiovascular disease 3) uncontrolled systemic disease 4) double cancers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety Disease Control Rate
- Secondary Outcome Measures
Name Time Method Overall Survival Progression Free Survival Response Rate